MAPT and Alzheimer disease: At the protein‐specific level, while the Alz‐Disc achieved a better accuracy on three proteins, APP, MAPT, and PRNP, our method is capable of accurately identifying the mutations from TREM2, a newly proposed AD biomarker, as we corrected the mutation labels of TREM2 in the primary dataset (Figure 5B).